Eli Lilly’s Foundayo Weight-Loss Pill: US Approval and First Data
Eli Lilly’s oral weight-loss medication Foundayo (forglipron) was prescribed 1,390 times in its first week following U.S. FDA approval on April 1, 2026, marking an early but notable uptake for ... Read More